Reply to: Eruptive Bowen's disease in a patient on pembrolizumab for Hodgkin's lymphoma.
Joana Cruañes-MonferrerFrancisco Martínez-DíazJuan Monte-SerranoMar García-GarcíaMaría Encarnación Giménez CortésPublished in: The Australasian journal of dermatology (2022)